Literature DB >> 6966549

Cell-mediated immunity to liver antigen in toxic liver injury. II. Role in pathogenesis of liver damage.

C I Smith, W G Cooksley, L W Powell.   

Abstract

The possible pathogenetic role of lymphocytes sensitized to liver antigens was investigated in CBA mice in which sublethal hepatic necrosis had been induced by carbon tetrachloride (CCl4). Sensitized lymphocytes from CCl4-treated mice were administered to syngeneic recipients. The recipients developed sensitivity to liver antigens but showed no evidence of liver damage. The cell mediating the immune response both in the donor and the recipient was a T cell. This was demonstrated further by studies involving mice rendered T cell deficient. These mice did not develop sensitized lymphocytes when they were treated with CCl4 but the extent of liver damage was similar in both T cell-depleted and intact animals. These findings suggest that T cell sensitization to liver antigens occurs as a result of toxic liver damage and does not play a role in the pathogenesis of the hepatic necrosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966549      PMCID: PMC1538134     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Studies on the cytotoxic effect of in vivo and in vitro immunized lymphocytes on liver target cells.

Authors:  H Warnatz; F Scheiffarth; R Schmeissner
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

3.  [Studies on the transfer of experimental hepatitis in the parabiose experiment].

Authors:  H Warnatz; F Scheiffarth; E Liebelt
Journal:  Z Immunitatsforsch Allerg Klin Immunol       Date:  1968-07

4.  Lymphocyte stimulation and chronic liver disease.

Authors:  H Tobias; A P Safran; F Schaffner
Journal:  Lancet       Date:  1967-01-28       Impact factor: 79.321

5.  Controlled study of autoimmunization against liver in inbred rat strains.

Authors:  B P Maclaurin
Journal:  Gut       Date:  1971-06       Impact factor: 23.059

6.  The distribution of chromium 51-labelled lymphoid cells in the mouse. A survey of anatomical compartments.

Authors:  M M Zatz; E M Lance
Journal:  Cell Immunol       Date:  1970-05       Impact factor: 4.868

7.  Autoradiographic experiments concerning the importance of mononuclear cells in experimental hepatitis.

Authors:  H Warnatz; F Scheiffarth; F Wolf; H J Schmidt
Journal:  J Immunol       Date:  1967-02       Impact factor: 5.422

8.  Studies concerning the importance of mononuclear cells in the development of experimental hepatitis.

Authors:  F Scheiffarth; H Warnatz; K Mayer
Journal:  J Immunol       Date:  1967-02       Impact factor: 5.422

9.  Immunological studies on the development of experimental hepatitis in thymectomized mice.

Authors:  F Scheiffarth; H Warnatz; H J Schmidt
Journal:  Int Arch Allergy Appl Immunol       Date:  1967

10.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

View more
  4 in total

1.  Antibody mediated hepatocyte injury in methyl dopa induced hepatotoxicity.

Authors:  J Neuberger; J G Kenna; K Nouri Aria; R Williams
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

2.  Study of cellular immunity in experimental autoimmune hepatitis in mice: transfer of spleen cells sensitized with liver proteins.

Authors:  Y Mori; T Mori; S Ueda; H Yoshida; K Iesato; Y Wakashin; M Wakashin; K Okuda
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

3.  Autoantibody responses to liver-specific lipoprotein in mice.

Authors:  W N Bartholomaeus; W D Reed; R A Joske; K B Shilkin
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

4.  EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against Cancer.

Authors:  Stephanie Rossnagl; Eva Altrock; Carla Sens; Sabrina Kraft; Katrin Rau; Michael D Milsom; Thomas Giese; Yvonne Samstag; Inaam A Nakchbandi
Journal:  PLoS Biol       Date:  2016-09-21       Impact factor: 8.029

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.